Skip to main content
欧康医药 logo

欧康医药 — Investor Relations & Filings

Ticker · 920230 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2024-09-26 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920230

About 欧康医药

https://www.okaypharm.com/

Oukang Pharmaceutical specializes in the research, development, and large-scale production of natural plant extracts, with a primary focus on citrus-derived flavonoids. The company’s core product portfolio includes high-purity ingredients such as Hesperidin, Diosmin, Methyl Hesperidin, and Neohesperidin Dihydrochalcone (NHDC). These products serve as essential raw materials for the global pharmaceutical, nutraceutical, food and beverage, and cosmetic sectors. Utilizing advanced extraction and purification technologies, the company maintains rigorous quality control standards to ensure compliance with international regulatory requirements. Its operations emphasize the industrialization of plant-based chemical derivatives to support diverse health and wellness applications.

Recent filings

Filing Released Lang Actions
关于调整2024年股权激励计划首次授予激励对象名单及授予权益数量的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding adjustments to the 2024 equity incentive plan, specifically about the initial grant of stock incentives to certain employees. It details board and supervisory approvals, legal opinions, and changes in the number of shares granted. There is no financial statement or comprehensive financial data presented. The document is a formal announcement of changes related to a share-based incentive plan, which is a capital-related update but not a full financing or capital raising event. It is not a report, earnings release, or management discussion. The content fits best under Capital/Financing Update (CAP) as it relates to equity incentive plan adjustments and share grants.
2024-09-26 Chinese
第四届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the fourth board of directors of Chengdu Oukang Pharmaceutical Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to related announcements on the stock exchange platform. The content focuses on board decisions regarding adjustments to the 2024 equity incentive plan and related stock grants. There is no financial data, earnings information, or detailed report content. The document is clearly a Board/Management Information announcement about board meeting resolutions and decisions, not a full report or financial statement.
2024-09-26 Chinese
第四届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the fourth supervisory board of Chengdu Oukang Pharmaceutical Co., Ltd. It details meeting attendance, agenda items, voting results, and references related announcements on the stock exchange platform. The content focuses on internal supervisory board decisions regarding adjustments to the 2024 equity incentive plan and the initial grant of restricted shares. There is no financial data, earnings information, or detailed report content. The document is an official announcement of board meeting resolutions rather than a full management report or financial filing. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or voting results announcement at a shareholder meeting, but a supervisory board meeting resolution announcement. Given the nature and length, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-09-26 Chinese
2024年股权激励计划首次授予激励对象名单（授予日）
Remuneration Information Classification · 95% confidence The document is a formal announcement from Chengdu Oukang Pharmaceutical Co., Ltd. regarding the initial grant list of incentive recipients under the 2024 equity incentive plan. It details the allocation of restricted stocks among directors, senior management, and core employees, including specific share quantities and percentages. The document includes a table of recipients and their roles, and it is signed by the company's board of directors with a date. There is no financial statement, audit information, or regulatory certification. The content focuses on equity incentive allocation, which is related to share-based compensation and management incentives. This type of announcement is best classified under Remuneration Information (DEF 14A), which covers reports detailing compensation plans for executives and directors, including equity incentive plans.
2024-09-26 Chinese
北京德恒（重庆）律师事务所关于成都欧康医药股份有限公司2024年第一次临时股东大会的法律意见
Regulatory Filings
2024-09-19 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 first extraordinary general meeting (临时股东大会) of Chengdu Oukang Pharmaceutical Co., Ltd. It includes information about the meeting date, location, attendance, agenda items, voting results, and legal opinions confirming the meeting's legality. The content focuses on shareholder meeting decisions, especially regarding the 2024 equity incentive plan and related authorizations. There are no financial statements or earnings data, nor is this a presentation or a report publication announcement. The document is clearly a formal announcement of shareholder meeting resolutions and voting results, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6284 characters) and detailed voting results support this classification with high confidence.
2024-09-19 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.